Literature DB >> 12800242

Expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor and its intervention by interleukin-10 in experimental hepatic fibrosis.

Xiao-Zhong Wang1, Zhi-Xin Chen, Li-Juan Zhang, Yun-Xin Chen, Dan Li, Feng-Lin Chen, Yue-Hong Huang.   

Abstract

AIM: To study the expression of IGF-1 and IGF-1R and its intervention by interleukin-10 in the course of experimental hepatic fibrosis.
METHODS: Hepatic fibrosis was induced in rats by carbon tetrachloride intoxication and liver specimens were taken from the rats administered CCl4 with or without IL-10 treatment and the animals of the control group. Immunoreactivities for insulin-like growth factor-1 (IGF-1) and IGF-1 receptor(IGF-1R) were demonstrated by immunohistochemistry, and their intensities were evaluated in different animal groups.
RESULTS: The positive levels for IGF-1 and IGF-1R were increased with the development of hepatic fibrosis, with the positive signals localized in cytoplasm and/or at the plasmic membrane of hepatocytes. The positive signals of IGF-1 and IGF-1R were observed more frequently (P<0.01) in the CCl4-treated group (92.0 % and 90.0 %) compared to those in the control group. The positive signals decreased significantly (P<0.05) in IL-10-treated group. The responses in IGF-1 and IGF-1R expression correlated with the time of IL-10 treatment.
CONCLUSION: The expression of IGF-1 and IGF-1R immunoreactivities in liver tissue seems to be up-regulated during development of hepatic fibrosis induced by CCl(4), and exogenic IL-10 inhibits the responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12800242      PMCID: PMC4611802          DOI: 10.3748/wjg.v9.i6.1287

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  50 in total

1.  Extraction and purification of TGFbeta and its effect on the induction of apoptosis of hepatocytes.

Authors:  X H Si; L J Yang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Inhibiting effect of antisense oligonucleotides phosphorthioate on gene expression of TIMP-1 in rat liver fibrosis.

Authors:  Q H Nie; Y Q Cheng; Y M Xie; Y X Zhou; Y Z Cao
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

3.  Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice.

Authors:  H Louis; O Le Moine; M O Peny; E Quertinmont; D Fokan; M Goldman; J Devière
Journal:  Hepatology       Date:  1997-06       Impact factor: 17.425

4.  Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension.

Authors:  Nimer Assy; M Paizi; D Gaitini; Y Baruch; G Spira
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

5.  Growth hormone therapy in patients with cirrhosis: a pilot study of efficacy and safety.

Authors:  A Donaghy; R Ross; C Wicks; S C Hughes; J Holly; A Gimson; R Williams
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

6.  High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance.

Authors:  E Shmueli; J P Miell; M Stewart; K G Alberti; C O Record
Journal:  Hepatology       Date:  1996-07       Impact factor: 17.425

7.  Expression of CD14 protein and its gene in liver sinusoidal endothelial cells during endotoxemia.

Authors:  Jian-Ping Gong; Li-Li Dai; Chang-An Liu; Chuan-Xin Wu; Yu-Jun Shi; Sheng-Wei Li; Xu-Hong Li
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

8.  Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis.

Authors:  J Kratzsch; W F Blum; E Schenker; E Keller
Journal:  Exp Clin Endocrinol Diabetes       Date:  1995       Impact factor: 2.949

9.  Effects of transmitters and interleukin-10 on rat hepatic fibrosis induced by CCl4.

Authors:  Xiao-Zhong Wang; Li-Juan Zhang; Dan Li; Yue-Hong Huang; Zhi-Xin Chen; Bin Li
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

10.  Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.

Authors:  S Møller; A Juul; U Becker; A Flyvbjerg; N E Skakkebaek; J H Henriksen
Journal:  J Clin Endocrinol Metab       Date:  1995-04       Impact factor: 5.958

View more
  7 in total

1.  Ginkgo biloba extract reverses CCl4-induced liver fibrosis in rats.

Authors:  Yan-Jun Luo; Jie-Ping Yu; Zhao-Hong Shi; Li Wang
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

2.  Altered expression of type I insulin-like growth factor receptor in Crohn's disease.

Authors:  F El Yafi; R Winkler; P Delvenne; N Boussif; J Belaiche; E Louis
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

3.  Increased hepatic expression of insulin-like growth factor-I receptor in chronic hepatitis C.

Authors:  Jose Tadeu Stefano; Maria Lucia Correa-Giannella; Cristiane Maria Freitas Ribeiro; Venancio Avancini Ferreira Alves; Paulo Celso Bosco Massarollo; Marcel Cerqueira Cesar Machado; Daniel Giannella-Neto
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

4.  Acute inflammation induces insulin-like growth factor-1 to mediate Bcl-2 and Muc5ac expression in airway epithelial cells.

Authors:  Hitendra S Chand; Zekarias Woldegiorgis; Kurt Schwalm; Jake McDonald; Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2012-08-09       Impact factor: 6.914

Review 5.  Interleukin-10 and chronic liver disease.

Authors:  Li-Juan Zhang; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

6.  IGF-1R contributes to stress-induced hepatocellular damage in experimental cholestasis.

Authors:  Axelle Cadoret; Colette Rey; Dominique Wendum; Khaldoun Elriz; François Tronche; Martin Holzenberger; Chantal Housset
Journal:  Am J Pathol       Date:  2009-07-23       Impact factor: 4.307

7.  Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.

Authors:  Yun-Lin Wu; Jing Ye; Shu Zhang; Jie Zhong; Rong-Ping Xi
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.